RG
APYX icon

Rathbones Group’s Apyx Medical APYX Stock Holding History

Rathbones Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-101,334
Closed -$139K – 629
2025
Q1 		$139K Hold
101,334
– – ﹤0.01% 551
2024
Q4 		$160K Sell
101,334
-150,000
-60% -$210K ﹤0.01% 548
2024
Q3 		$312K Hold
251,334
– – ﹤0.01% 477
2024
Q2 		$337K Buy
251,334
+150,000
+148% +$221K ﹤0.01% 467
2024
Q1 		$138K Hold
101,334
– – ﹤0.01% 564
2023
Q4 		$265K Hold
101,334
– – ﹤0.01% 489
2023
Q3 		$324K Buy
+101,334
New +$472K ﹤0.01% 462

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return